CERNEVIT FOR INJECTION
Product details
Registration number: SIN11975P
Classification: General Sale List
Active ingredients:
- ASCORBIC ACID
- CHOLECALCIFEROL
- COCARBOXYLASE TETRAHYDRATE EQV THIAMINE
- CYANOCOBALAMIN
- D-BIOTIN
- DEXPANTHENOL EQV PANTOTHENIC ACID
- DL ALPHA-TOCOPHEROL EQV ALPHA-TOCOPHEROL
- FOLIC ACID
- NICOTINAMIDE
- PYRIDOXINE HCl EQV PYRIDOXINE
- RETINOL PALMITATE EQV RETINOL
- RIBOFLAVIN DIHYDRATED SODIUM PHOSPHATE EQV RIBOFLAVIN
Strength:
- 125 mg/vial
- 220 iu/vial
- 3.51 mg/vial
- 0.006 mg/vial
- 0.069 mg/vial
- 17.25 mg/vial
- 11.2 iu/vial
- 0.414 mg/vial
- 46 mg/vial
- 4.53 mg/vial
- 3500 iu/vial
- 4.14 mg/vial
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Registrant: BAXTER HEALTHCARE (ASIA) PTE LTD
ATC code: B05XC
HSA approval date: 5 June 2002
Manufacturer(s):
- FAREVA PAU 1 (Sub-contractor)
- Baxter S.A.
Manufacturing country/countries: FRANCE; BELGIUM
What are the HSA registration number and classification for CERNEVIT FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN11975P
Classification: General Sale List
What active ingredients and strength are recorded for CERNEVIT FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- ASCORBIC ACID
- CHOLECALCIFEROL
- COCARBOXYLASE TETRAHYDRATE EQV THIAMINE
- CYANOCOBALAMIN
- D-BIOTIN
- DEXPANTHENOL EQV PANTOTHENIC ACID
- DL ALPHA-TOCOPHEROL EQV ALPHA-TOCOPHEROL
- FOLIC ACID
- NICOTINAMIDE
- PYRIDOXINE HCl EQV PYRIDOXINE
- RETINOL PALMITATE EQV RETINOL
- RIBOFLAVIN DIHYDRATED SODIUM PHOSPHATE EQV RIBOFLAVIN
Strength:
- 125 mg/vial
- 220 iu/vial
- 3.51 mg/vial
- 0.006 mg/vial
- 0.069 mg/vial
- 17.25 mg/vial
- 11.2 iu/vial
- 0.414 mg/vial
- 46 mg/vial
- 4.53 mg/vial
- 3500 iu/vial
- 4.14 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for CERNEVIT FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for CERNEVIT FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Registrant: BAXTER HEALTHCARE (ASIA) PTE LTD
Which manufacturers and countries are listed for CERNEVIT FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- FAREVA PAU 1 (Sub-contractor)
- Baxter S.A.
Manufacturing country/countries: FRANCE; BELGIUM
Where can I look up CERNEVIT FOR INJECTION in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN11975P or the exact product name CERNEVIT FOR INJECTION. The general register link does not preselect this product.
What are the source dates for this CERNEVIT FOR INJECTION record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this CERNEVIT FOR INJECTION record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN11975P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)